Helicobacter pylori vaccines—the current status

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Alimentary Pharmacology & Therapeutics

• Publication date

  2000-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1046/j.1365-2036.2000.00825.x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies

  2000cited by this paper
• Pilot Study of phoP/phoQ-DeletedSalmonella enterica Serovar Typhimurium ExpressingHelicobacter pylori Urease in Adult Volunteers

  2000cited by this paper
• Injection of plasmid DNA into the gastric mucosa induces mucosal and systemic immunity.

  2000cited by this paper
• Immunization with Recombinant Helicobacter pylori Urease in Specific-Pathogen-Free Rhesus Monkeys (Macaca mulatta)

  2000cited by this paper
• Parenteral Adjuvant Activities of Escherichia coli Heat-Labile Toxin and Its B Subunit for Immunization of Mice against Gastric Helicobacter pyloriInfection

  2000cited by this paper
• Further development of the Helicobacter pylori mouse vaccination model.

  2000cited by this paper
• Immunogenicity of a Salmonella typhimurium aroA aroD Vaccine Expressing a Nontoxic Domain of Clostridium difficile Toxin A

  1999cited by this paper
• Role of Gamma Interferon in Helicobacter pylori-Induced Gastric Inflammatory Responses in a Mouse Model

  1999cited by this paper
• Comparison between targeted and untargeted systemic immunizations with adjuvanted urease to cure Helicobacter pylori infection in mice.

  1999cited by this paper
• Poliovirus replicons encoding the B subunit of Helicobacter pylori urease elicit a Th1 associated immune response.

  1999cited by this paper
• Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.

  1999cited by this paper
• Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice.

  1999cited by this paper
• Protection against Helicobacter pylori infection by intestinal immunisation with a 50/52-kDa subunit protein.

  1999cited by this paper
• Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.

  1999cited by this paper
• Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.

  1999cited by this paper
• Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys.

  1999cited by this paper
• Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles.

  1999cited by this paper
• Local Secretory Immunoglobulin A and Postimmunization Gastritis Correlate with Protection against Helicobacter pylori Infection after Oral Vaccination of Mice

  1999cited by this paper
• Helicobacter pylori Infection in Immunized Mice Lacking Major Histocompatibility Complex Class I and Class II Functions

  1999cited by this paper
• Replication-Defective Adenovirus Infection ReducesHelicobacter felis Colonization in the Mouse in a Gamma Interferon- and Interleukin-12-Dependent Manner

  1999cited by this paper
• Immunization of Mice with Urease Vaccine Affords Protection against Helicobacter pylori Infection in the Absence of Antibodies and Is Mediated by MHC Class II–restricted Responses

  1998cited by this paper
• Immunization against Natural Helicobacter pylori Infection in Nonhuman Primates

  1998cited by this paper
• Rectal and Intranasal Immunizations with Recombinant Urease Induce Distinct Local and Serum Immune Responses in Mice and Protect against Helicobacter pyloriInfection

  1998cited by this paper
• Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B.

  1998cited by this paper
• Mice Are Protected from Helicobacter pylori Infection by Nasal Immunization with AttenuatedSalmonella typhimurium phoPc Expressing Urease A and B Subunits

  1998cited by this paper
• Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral imm_unization of mice against Helicobacter felis

  1998cited by this paper
• Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant.

  1998cited by this paper
• Systemic immunization with urease protects mice against Helicobacter pylori infection.

  1998cited by this paper
• Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype.

  1998cited by this paper
• Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection.

  1998cited by this paper
• Vaccination of gnotobiotic piglets against Helicobacter pylori.

  1998cited by this paper
• Antibiotic resistance in Helicobacter pylori infection.

  1998cited by this paper
• Post-immunization gastritis in helicobacter immunized/challenged mice

  1998cited by this paper
• Murine CD4 T-cell response to Helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load.

  1997cited by this paper
• Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria.

  1997cited by this paper
• Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

  1997cited by this paper
• Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice.

  1997cited by this paper
• Promotion of Ulcerative Duodenitis in Young Ferrets by Oral Immunization with Helicobacter mustelae and Muramyl Dipeptide

  1997cited by this paper
• Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection.

  1997cited by this paper
• A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain.

  1997cited by this paper
• T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.

  1997cited by this paper
• Frontiers in Helicobacter pylori research: pathogenesis, host response, vaccine development and new therapeutic approaches.

  1996cited by this paper
• Generation of a monoclonal antibody to a defined portion of the Helicobacter pylori vacuolating cytotoxin by DNA immunization.

  1996cited by this paper
• Therapeutic immunization against Helicobacter mustelae in naturally infected ferrets.

  1996cited by this paper
• Factors associated with serum antibodies to reticulin, endomysium, and gliadin in an adult population.

  1996cited by this paper
• Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice.

  1996cited by this paper
• Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.

  1995cited by this paper
• Development of a mouse model of Helicobacter pylori infection that mimics human disease

  1995cited by this paper
• Effect of oral immunization with recombinant urease on murine Helicobacter felis gastritis

  1995cited by this paper
• Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4.

  1995cited by this paper
• Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis.

  1995cited by this paper
• Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.

  1994cited by this paper
• Successful immunization against gastric infection with Helicobacter species: use of a cholera toxin B-subunit-whole-cell vaccine

  1994cited by this paper
• Live oral vaccines against cholera: an update.

  1993cited by this paper
• Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization.

  1993cited by this paper
• Interferon-gamma and Tumour Necrosis Factor Production in Patients withHelicobacter pylori Infection

  1993cited by this paper
• Post-marketing experience with live oral Ty21a vaccine.

  1993cited by this paper
• Immunisation against gastric helicobacter infection in a mouse/Helicobacter felis model.

  1992cited by this paper
• Oral immunization against Helicobacter pylori

  1991cited by this paper
• A small animal model of human Helicobacter pylori active chronic gastritis.

  1990cited by this paper
• Local immune response to gastric Campylobacter in non-ulcer dyspepsia.

  1986cited by this paper

• Screening and eradication of Helicobacter pylori for gastric cancer prevention: Taipei Global Consensus II

  2025cites this paper
• Coculture at the crossroads of the new microbiology techniques for the isolation of strict intracellular bacteria.

  2020cites this paper
• Vitamin D3 Inhibits Helicobacter pylori Infection by Activating the VitD3/VDR-CAMP Pathway in Mice

  2020cites this paper
• Status of vaccine research and development for Helicobacter pylori

  2019cites this paper
• Anti-urease immunoglobulin (IgY) from egg yolk prevents Helicobacter pylori infection in a mouse model

  2019cites this paper
• The Laboratory Ferret

  2017cites this paper
• Diagnosis and treatment in Helicobacter pylori infection.

  2010cites this paper
• Helicobacter pylori vaccine: from past to future.

  2008cites this paper
• Is vaccinatie tegen Helicobacter pylori spoedig te verwachten

  2006cites this paper
• Recombinant bacterial ghosts: versatile targeting vehicles and promising vaccine candidates.

  2004cites this paper
• Animal models of Helicobacter pylori infection and disease.

  2003cites this paper
• Helicobacter pylori vaccines spiral into the new millennium.

  2003cites this paper
• Different T helper type immune responses induced by Helicobacter pylori vaccine in mouse model

  2003cites this paper
• Generation of Helicobacter pylori Ghosts by PhiX Protein E-Mediated Inactivation and Their Evaluation as Vaccine Candidates

  2003cites this paper
• Helicobacter pylori and Peptic Ulcer Disease

  2003cites this paper
• Immunization with Attenuated Salmonella typhimurium Producing Catalase in Protection against Gastric Helicobacter pylori Infection in Mice

  2003cites this paper
• Dynamics of Helicobacter pylori infection in early childhood in a high‐risk group living in Germany: loss of infection higher than acquisition

  2002cites this paper
• Traditional and Molecular Techniques for the Study of Emerging Bacterial Diseases: One Laboratory’s Perspective

  2002cites this paper
• Helicobacter pylori Infection as a Model for Gastrointestinal Immunity and Chronic Inflammatory Diseases

  2001cites this paper
• The role of H pylori in gastrointestinal disease

  2001cites this paper